Top Markets
Coin of the day
Suzhou Basecare Medical Corporation Limited Suzhou Basecare Medical Corporation Limited

Suzhou Basecare Medical Corporation Limited

2170
株式のランク #25425
Suzhou Basecare Medical Corporation Limited, an investment holding company... Suzhou Basecare Medical Corporation Limited, an investment holding company established in Suzhou, China, in 2010, focuses its business activities within the People's Republic of China. The company primarily engages in the research, development, and manufacturing of genetic testing solutions specifically for assisted reproduction, alongside the distribution of related medical devices and instruments. Its extensive product line includes a range of genetic test kits for reproductive health. These comprise pre-implantation genetic tests such as PGT-A, designed to screen for chromosomal aneuploidies; PGT-M, which identifies single-gene or monogenic defects in pre-implantation embryos; and PGT-SR kits, used to detect chromosomal structural rearrangements often linked to recurrent miscarriages. Additionally, Basecare offers prenatal test kits (CNV kits) and postnatal test kits (WES kits). Complementing its genetic testing offerings, the company supplies various specialized medical equipment, including liquid nitrogen storage dewars, cryostorage systems, automated workstations, sperm quality analyzers, and next-generation sequencing (NGS) sequencers. Beyond manufacturing and sales, Basecare also provides marketing services and develops software for its medical devices and instruments. Its primary clientele consists of hospitals and reproductive clinics.
株価
$0.18165525
最終同期: 2026-08-20
時価総額
$49.69M
変化(1日)
1.07%
変化(1年)
-60.57%
CN
取引 Suzhou Basecare Medical Corporation Limited (2170)

カテゴリー

Suzhou Basecare Medical Corporation Limited(2170)の利益
2026 時点の利益 TTM: 0
Suzhou Basecare Medical Corporation Limited の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Suzhou Basecare Medical Corporation Limited の利益の推移(2026 〜 2026)
各年末の利益
利益 変化
提供された日付のデータは十分ではありません。
同業他社の利益
企業 利益 利益の差
$7.51B -
US
$5.15B -
US
$5.56B -
IE
$3.86B -
US
- -
DE